|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/454 | |||
| A61K 45/06 | |||
| A61P 37/02 | |||
| A61P 37/04 | |||
| A61K 31/522 |
| (11) | Patento numeris | 1924250 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05852555.1 |
| Europos patento paraiškos padavimo data | 2005-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-05-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/043360 |
| Data | 2005-11-30 |
| (87) | Numeris | WO 2006/060507 |
| Data | 2006-06-08 |
| (30) | Numeris | Data | Šalis |
| 631870 P | 2004-12-01 | US |
| (72) |
XU, Weiming, US
CORRAL, Laura, G., US
|
| (73) |
CELGENE CORPORATION,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS |
| METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS |